We are live on
!
Find out more
AL
ACAS LLC Portfolio holdings
AUM
$149M
1-Year Est. Return
16.56%
This Fund
S&P 500
This Quarter
Est. Return
+6.5%
1 Year Est. Return
+16.56%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$70.7M
AUM Growth
+$6.83M
(+11%)
Cap. Flow
+$2.62M
Cap. Flow
% of AUM
3.71%
Top 10 Holdings %
Top 10 Hldgs %
46.21%
Holding
79
New
4
Increased
37
Reduced
22
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$338K |
| 2 |
SPDR Gold Trust
GLD
|
+$264K |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$251K |
| 4 |
Vanguard International Dividend Appreciation ETF
VIGI
|
+$222K |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$204K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares CMBS ETF
CMBS
|
+$234K |
| 2 |
Pfizer
PFE
|
+$148K |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$26K |
| 4 |
iShares MSCI Emerging Markets Asia ETF
EEMA
|
+$24.7K |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$19.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.83% |
| 2 | Consumer Discretionary | 6.02% |
| 3 | Consumer Staples | 2.02% |
| 4 | Financials | 1.92% |
| 5 | Healthcare | 1.68% |
Similar funds
CMS
RP
EFA
PWM
SCM
DWM
BMD
BDCM
ACAS LLC's Q2 2021 Portfolio in Review
As of Q2 2021, ACAS LLC held 79 positions worth $70.7M, up 11% from $63.8M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
ACAS LLC deployed $2.62M of net new capital in Q2 2021, opening 4 new positions and adding to 37 existing holdings. Its largest new stake was SPDR Gold Trust: 1,553 shares worth $257K.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Pfizer, an estimated $148K trimmed.
- ACAS LLC's largest Q2 2021 buy was SPDR Gold Trust: 1,553 shares worth $257K.
- ACAS LLC added most to iShares S&P 500 Growth ETF in Q2 2021, an estimated $338K increase.
- ACAS LLC's biggest Q2 2021 reduction was Pfizer, cutting an estimated $148K.
- ACAS LLC fully exited iShares CMBS ETF in Q2 2021, selling an estimated $234K.
- ACAS LLC's ten largest holdings make up 46% of its $70.7M portfolio in Q2 2021.
- ACAS LLC opened 4 new positions and closed 1 in Q2 2021.
- ACAS LLC's portfolio value rose 11% quarter-over-quarter to $70.7M.
Based on ACAS LLC's 13F filing for Q2 2021, filed 14 Jul 2021.